E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 8/11/2006 in the Prospect News Biotech Daily.

Rodman & Renshaw taps Chambers for senior managing director

By Laura Lutz

Des Moines, Aug. 11 - Rodman & Renshaw, LLC appointed John Chambers as a senior managing director, according to a company release.

Chambers' responsibilities will include pursuing and arranging financing and financial advisory transactions for public and private life sciences companies.

Chambers was most recently a managing director and senior biotechnology specialist at SG Cowen. Before that, he was a managing director and senior banker for the biotechnology sector at Lehman Brothers, a managing director and senior banker for the biotechnology sector at UBS and a senior officer in the healthcare group at Salomon Smith Barney.

"We are delighted that John has joined our team. His experience, knowledge and extensive relationships in the life sciences sector will be of great value to Rodman & Renshaw and its clients as we continue to build the firm," Rodman & Renshaw president John J. Borer, III, said in the release.

Rodman & Renshaw is a New York-based investment bank.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.